16th Dec 2020 07:00
Ap19
FORM 8.3 Amendment to Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 10 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,050,061 | 2.37% | 690,622 | 0.54% | ||
(2) | Derivatives (other than options): | ||||
365,705 | 0.28% | 739,005 | 0.57% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
| TOTAL: | |||||
3,415,766 | 2.66% | 1,429,627 | 1.11% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 1 | 207.4100 USD |
Purchase | 2 | 207.5537 USD |
Purchase | 4 | 206.7225 USD |
Purchase | 4 | 206.4300 USD |
Purchase | 7 | 207.1285 USD |
Purchase | 8 | 206.7062 USD |
Purchase | 9 | 206.9600 USD |
Purchase | 10 | 206.5320 USD |
Purchase | 10 | 206.8090 USD |
Purchase | 12 | 206.7500 USD |
Purchase | 12 | 207.2587 USD |
Purchase | 13 | 206.8530 USD |
Purchase | 14 | 207.0000 USD |
Purchase | 21 | 206.7766 USD |
Purchase | 24 | 205.9662 USD |
Purchase | 38 | 205.8800 USD |
Purchase | 49 | 205.8248 USD |
Purchase | 75 | 206.0933 USD |
Purchase | 192 | 206.7897 USD |
Purchase | 195 | 206.3376 USD |
Purchase | 227 | 205.7362 USD |
Purchase | 300 | 207.4256 USD |
Purchase | 388 | 206.2451 USD |
Purchase | 580 | 206.8575 USD |
Purchase | 786 | 205.9283 USD |
Purchase | 979 | 205.7588 USD |
Purchase | 1,223 | 206.8215 USD |
Purchase | 1,980 | 206.2361 USD |
Purchase | 2,477 | 206.0455 USD |
Purchase | 2,599 | 206.8174 USD |
Purchase | 2,660 | 206.7572 USD |
Purchase | 3,513 | 206.8200 USD |
Purchase | 3,582 | 207.0029 USD |
Purchase | 5,236 | 205.9211 USD |
Purchase | 7,777 | 207.0707 USD |
Purchase | 15,135 | 206.7458 USD |
Purchase | 23,472 | 206.5651 USD |
Sale | 1 | 206.3000 USD |
Sale | 1 | 206.9600 USD |
Sale | 1 | 206.8600 USD |
Sale | 1 | 206.7000 USD |
Sale | 2 | 206.3700 USD |
Sale | 2 | 206.8350 USD |
Sale | 6 | 207.1800 USD |
Sale | 6 | 206.9025 USD |
Sale | 7 | 206.4564 USD |
Sale | 9 | 206.6677 USD |
Sale | 10 | 206.8000 USD |
Sale | 20 | 207.2200 USD |
Sale | 42 | 206.5530 USD |
Sale | 44 | 206.5236 USD |
Sale | 100 | 207.6450 USD |
Sale | 106 | 207.5733 USD |
Sale | 200 | 206.8400 USD |
Sale | 205 | 205.9836 USD |
Sale | 240 | 207.5200 USD |
Sale | 287 | 206.5232 USD |
Sale | 306 | 206.0471 USD |
Sale | 329 | 207.0875 USD |
Sale | 507 | 206.2617 USD |
Sale | 600 | 206.9766 USD |
Sale | 827 | 206.3314 USD |
Sale | 889 | 206.2789 USD |
Sale | 914 | 206.2501 USD |
Sale | 1,014 | 206.4174 USD |
Sale | 1,111 | 206.7214 USD |
Sale | 1,333 | 206.8273 USD |
Sale | 2,237 | 206.3718 USD |
Sale | 2,598 | 206.8173 USD |
Sale | 3,498 | 206.8200 USD |
Sale | 3,623 | 206.4318 USD |
Sale | 4,647 | 206.7790 USD |
Sale | 5,936 | 206.8881 USD |
Sale | 9,725 | 206.8369 USD |
Sale | 10,000 | 205.9420 USD |
Sale | 11,214 | 206.7326 USD |
Sale | 11,669 | 206.7665 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 16 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
View source version on businesswire.com: https://www.businesswire.com/news/home/20201215006206/en/
Copyright Business Wire 2020
Related Shares:
Barclays